Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07688278

HbA1c Screening in Dental Care and Primary Care Referral in Patients With Advanced Periodontitis

This study will evaluate whether HbA1c screening can be performed in dental care to detect elevated blood glucose in patients with advanced periodontitis and support referral to primary care.

Periodontitis is a common chronic inflammatory disease affecting the supporting tissues of the teeth. Advanced periodontitis is associated with prediabetes, type 2 diabetes and cardiovascular disease. The relationship between periodontitis and diabetes is bidirectional: diabetes increases the risk and severity of periodontitis, while periodontal inflammation may contribute to impaired glucose regulation. Patients with advanced periodontitis may therefore represent a group at increased risk of undetected elevated blood glucose. Many of these patients visit dental care regularly but may not otherwise be reached by structured medical prevention.

This is a cross-sectional observational feasibility study conducted in public dental clinics in Skåne, Sweden, in collaboration with primary care. Adult patients aged 18 years or older with advanced periodontitis, defined as periodontitis stage 3-4 or grade B/C, will be invited to participate during a routine dental visit. Patients with previously diagnosed diabetes will not be included.

After informed consent, participants will complete or update a health declaration and undergo capillary HbA1c testing at the dental clinic using a validated point-of-care instrument. Participants will receive their test result. Those with HbA1c ≥42 mmol/mol will receive standardized information and be referred to their listed primary care centre for further diagnostic assessment and preventive follow-up according to routine clinical practice.

The study will assess how feasible this pathway is in routine dental care. Outcomes include participation rate, successful HbA1c testing, time required for study procedures, prevalence of elevated HbA1c, proportion referred to primary care, completed primary care follow-up within six months, dropout and costs. Follow-up data will be collected from medical records and regional registers.

The study may provide a practical model for collaboration between dental care and primary care, with the long-term aim of improving early detection of prediabetes and diabetes and strengthening preventive care for patients with advanced periodontitis.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Folktandvården Skåne AB

Skåne, Sweden

Location status: Recruiting

Location contact

Nils Oscarson

CONTACT

[email protected]

+46 70 277 33 57

Nils Oscarson

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 years or older.
  • Advanced periodontitis, defined as stage 3-4 periodontitis or grade B/C periodontitis according to clinical and radiographic assessment during routine dental care.
  • Ability to understand study information and provide informed consent.

Exclusion criteria

  • Previously diagnosed diabetes mellitus.
  • Inability to provide informed consent, for example due to severe mental disorder or markedly impaired health status as judged by the clinical staff.

Treatment and study plan

Point-of-care HbA1c screening

Diagnostic Test

All participants undergo capillary HbA1c testing at the dental clinic using a validated point-of-care instrument. Test results are provided to the participant during the visit.

Conditional standardized primary care referral

Other

Participants with HbA1c ≥42 mmol/mol receive standardized information about the elevated test result and are referred to their listed primary care centre for further diagnostic assessment and preventive follow-up according to routine clinical practice.

Primary outcomes

  1. Participation rate

    Time frame: 6 months

    Number of participants included out of those who meet the inclusion criteria. Reasons for non-participation will be recorded in free text.

Secondary outcomes

  1. Proportion of participants with HbA1c 42 mmol/mol or higher.

    Time frame: 6 months

    Proportion of participants with HbA1c 42 mmol/mol or higher

  2. Proportion of patients undergoing blood pressure examination at follow-up in primary care

    Time frame: 6 months

    Through review of medical records at the patient's primary health care center, assessment of proportion of patients undergoing blood pressure examination.

  3. Proportion of patients undergoing blood lipid laboratory samples

    Time frame: 6 months

    Through review of medical records in primary care, assessment of proportion of patients undergoing blood lipid laboratory sample.

  4. Diagnosis at follow-up

    Time frame: 6 months

    Diagnosis registered at the follow-up in primary care

  5. Proportion of patients receiving lifestyle advice at follow-up

    Time frame: 6 months

    Through review of medical records at follow-up in primary care, assessment of proportion of patients receiving advice on lifestyle habits.

Study contacts

Contact information is provided by the study sponsor or research team.

Peter Nymberg

CONTACT

[email protected]

Susanna Calling

CONTACT

[email protected]

+46724640728

Sponsors and collaborators

Lead sponsor

Region Skane

Other

Collaborators

  • Folktandvården Skåne AB

Registry information

Official study title

Early Detection of Elevated Blood Sugar in Patients With Advanced Periodontitis: a Feasibility Study

Acronym: DENT-PC

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jul 7, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.